4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001140361-22-030302
President and CEO sold 14,806 shares at $5.04 ($74,548)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Touchon Pascal President and CEO | 2022-08-16 | Sale | −14,806 | $5.04 | $74,548 | 457,287 | D |
| Open-market sales · 14,806 sh · avg $5.04 · $74,548 | |||||||
Loading xslF345X03/form4.xml…